Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use

AIDS

Volumn 14, Issue 10, 2000, Pages 1453-1454

  Moyle, Graeme J ^a   Wilkins, Ed ^b   Leen, Clifford ^c   Cheesbrough, Ann ^a   Reynolds, Brian ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c Glaxo Wellcome ^*

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; EFAVIRENZ; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR;

CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; VIRUS LOAD;

ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; NEVIRAPINE; OXAZINES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SALVAGE THERAPY;

EID: 0033910325     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200007070-00020     Document Type: Letter

References (2)